학술논문

Ibrutinib dose modifications for management of cardiac adverse events in patients with B-cell malignancies: Pooled analysis of 10 clinical trials.
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p7538-7538, 1p
Subject
Language
ISSN
0732183X